Teva clarifies counterfeit remarks
This article was originally published in Scrip
Executive Summary
Ruud van Anraat, Teva's director of public affairs, wishes to clarify remarks he made during a session on counterfeit pharmaceuticals at a recent TOPRA (The Organisation for Professionals in Regulatory Affairs) conference in Brussels, Belgium (scripnews.com, March 3rd, 2009).